Inflammatory breast carcinoma incidence and survival: The Surveillance, Epidemiology, and End Results program of the National Cancer Institute, 1975- 1992

Cancer

Volumn 82, Issue 12, 1998, Pages 2366-2372

  Chang, Shine ^a   Parker, Sheryl L ^b   Pham, Tuan ^a   Buzdar, Aman U ^a   Hursting, Stephen D ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

Incidence; Inflammatory breast carcinoma; SEER; Survival; Trends

Indexed keywords

AGE; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; CAUCASIAN; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

ADENOCARCINOMA; ADULT; AFRICAN AMERICANS; AGE OF ONSET; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; RISK FACTORS; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 0032526003     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980615)82:12<2366::AID-CNCR10>3.0.CO;2-N     Document Type: Article

References (18)

1. Levine PH, Steinhorn SC, Ries LG, Aron JL. Inflammatory breast cancer: the experience of the Surveillance, Epidemiology, and End Results (SEER) program. J Natl Cancer Inst 1985;74:291-7.
2. Singletary SE, Ames FC, Buzdar AU. Management of inflammatory breast cancer. World J Surg 1994;18:87-92.
3. Jaiyesimi IA, Buzdar AU, Hortobagyi G. Inflammatory breast cancer: a review. J Clin Oncol 1992;10:1014-24.
4. Hortobagyi G, Singletary SE, McNeese MD. Treatment of locally advanced and inflammatory breast cancer. In: Harris JR, Lippman ME, Morrow M, Hellmen S, editors. Diseases of the breast. Philadelphia: Lippincott-Raven, 1996: 585-600.
5. Percy C, Van Holten V, Muir C, editors. International classification of diseases for oncology. 2nd edition. Geneva: World Health Organization, 1990.
6. Ries, LAG, Kosary, CL, Hankey, BF. SEER cancer statistics review, 1973-1993: tables and graphs. NIH Publication No. 96-2789. Bethesda, MD: National Cancer Institute. 1995.
7. United States Bureau of the Census. Current population reports, P-25-1130, population projections of the United States, by age, sex, race, and Hispanic origin: 1995 to 2050. Washington, DC: U.S. Government Printing Office, 1996.
8. United States Bureau of the Census. Current population reports, P25-1127, national and state population estimates: 1990 to 1994. Washington, DC: U.S. Government Printing Office, 1995.
9. Fleiss JL. Statistical methods for rates and proportions. 2nd edition. New York: John Wiley & Sons, Inc., 1981.
10. Remington RD, Schork MA. Statistics with applications to the biological and health sciences. 2nd edition. Englewood Cliffs: Prentice-Hall, 1985.
11. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
12. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. Atlanta, GA: American Cancer Society, 1997.
13. American Joint Committee on Cancer. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Manual for staging of cancer. 4th edition. Philadelphia: J. B. Lippincott, 1992.
14. Ries LG, Henson DE, Harras A. Survival from breast cancer according to tumor size and nodal status. Medicolegal controversies in breast cancer: biologic basis and risk prevention. 1994;3:35-53.
15. Lopez MJ, Porter KA. Inflammatory breast cancer. Surg Clin North Am 1996;76:411-29.
16. Parker SL, Wingo PA, Heath CW. Breast cancer facts and figures, 1996. Atlanta, GA: American Cancer Society, 1996.
17. Buzdar AU, Singletary SE, Booser DJ, Frye DK, Wasaff B, Hortobagyi G. Combined modality treatment of stage III and inflammatory breast cancer: M. D. Anderson Cancer Center experience. Surg Oncol Clin North Am 1995;4:715-34.
18. Hortobagyi G, Buzdar AU. Locally advanced breast cancer: a review including the M. D. Anderson experience. In: Ragaz J, Ariel IM. High-risk breast cancer. Berlin: Springer-Verlag, 1991:382-415.